Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Mesa Laboratories (MLAB) stock in plain English

Free brief · no signupStart here
MLABPublished Nov 15, 2026
Mesa Laboratories Inc
Technology · Scientific & Technical Instruments
Manufactures quality control instruments, biological indicators, and automated testing systems for healthcare and life science facilities.
Assets:
Gyrolab immunoassay platformAutomates nanoliter-scale protein analysis for biopharmaceutical labs.
Bozeman manufacturing plantProduces biological indicators used for medical sterilization validation.
Calibration and torque toolsBuilds measurement hardware for packaging lines and medical equipment.
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

47
OPS ScoreOperating finances
Latest quote
-3.19%$133.41
$749.83M
115.9×
$251.62M

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 15, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was MLAB. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Mesa Laboratories (MLAB) do?

Mesa Laboratories Inc (MLAB) is a U.S.-listed company in Technology (Scientific & Technical Instruments). What it does: Manufactures quality control instruments, biological indicators, and automated testing systems for healthcare and life science facilities. It is worth $749.83M on the market and sold $251.62M over the last year.

Market cap
$749.83M
P/E ratio
115.9×
Annual sales
$251.62M
Sector
Technology
Industry
Scientific & Technical Instruments
Brief updated
Nov 15, 2026

Brands and businesses behind MLAB

  • Gyros Protein Technologies: Sells automated microfluidic immunoassay platforms and consumable discs to biopharmaceutical research laboratories.
  • Agena Bioscience: Sells mass spectrometry genetic analysis instruments and consumable reagent panels for clinical diagnostics.

MLAB’s flags, in plain English

Each flag is a number from Mesa Laboratories’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 15, 2026.

Wide Gross Margin

Gross margin of 58.1% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Stupid Cash

Can pay this year's bills 1.9 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Still Climbing

Sales up 13.2% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.

Priced for Perfection

Priced at 115.9 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.

1 more green flag and 1 more risk note open with the free trial. Try it free for 7 days.

Questions about MLAB

How big is Mesa Laboratories?

Mesa Laboratories’ market cap is $749.83M: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $251.62M: what customers paid the company over the last year, before any costs.

What is MLAB’s P/E ratio?

MLAB’s P/E ratio is 115.9×. Investors pay about 115.9 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with MLAB?

Biopharmaceutical customers have curtailed spending on instruments and consumables across recent operating quarters. That is one risk on Mesa Laboratories’ card. Its first risk flag is Priced for Perfection, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Mesa Laboratories’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. MLAB’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card